10/28/2024 8:40 PM | Bioxytran (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024 4:59 PM | Bioxytran (Issuer) Utter Anders (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 5:06 PM | Bioxytran (Issuer) PLATT DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 5:09 PM | Bioxytran (Issuer) MILANOVA RADKA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 4:21 PM | Bioxytran (Issuer) Hoberman Alan M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 4:29 PM | Bioxytran (Issuer) Soderquist Ola (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 4:32 PM | Bioxytran (Issuer) CONAWAY DALE H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
10/28/2024 4:35 PM | Bioxytran (Issuer) Sheikh Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 4:59 PM | Bioxytran (Issuer) Sheikh Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:02 PM | Bioxytran (Issuer) Soderquist Ola (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 4:30 PM | Bioxytran (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 4:26 PM | Bioxytran (Issuer) MILANOVA RADKA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 4:10 PM | Bioxytran (Issuer) PLATT DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:39 PM | Bioxytran (Issuer) Hoberman Alan M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:46 PM | Bioxytran (Issuer) CONAWAY DALE H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:52 PM | Bioxytran (Issuer) Utter Anders (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 5:02 AM | Bioxytran (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 5:03 AM | Bioxytran (Filer)
| Form RW | |
07/03/2024 7:06 PM | Bioxytran (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:43 PM | Bioxytran (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2024 2:39 PM | Bioxytran (Filer)
| Form 10-Q/A | |
04/19/2024 3:50 PM | Bioxytran (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024 3:25 PM | Bioxytran (Issuer) MILANOVA RADKA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 3:26 PM | Bioxytran (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 3:21 PM | Bioxytran (Issuer) Hoberman Alan M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 3:23 PM | Bioxytran (Issuer) CONAWAY DALE H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 1:46 PM | Bioxytran (Issuer) MILANOVA RADKA (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/27/2024 4:56 PM | Bioxytran (Issuer) CONAWAY DALE H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:58 PM | Bioxytran (Issuer) Utter Anders (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:48 PM | Bioxytran (Issuer) Hoberman Alan M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:53 PM | Bioxytran (Issuer) PLATT DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:17 PM | Bioxytran (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
01/16/2024 9:00 AM | Bioxytran (Issuer) PLATT DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 9:03 AM | Bioxytran (Issuer) Hoberman Alan M (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/16/2024 9:06 AM | Bioxytran (Issuer) CONAWAY DALE H (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/16/2024 9:09 AM | Bioxytran (Issuer) Utter Anders (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/16/2024 8:53 AM | Bioxytran (Issuer) Chen-Walden Hana (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |